Company Registration No. 12808225 (England and Wales)
THE MEDISERVE CLINIC LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 JANUARY 2026
THE MEDISERVE CLINIC LIMITED
CONTENTS
Page
Company information
1
Directors' report
2
Statement of income and retained earnings
3
Balance sheet
4
Notes to the financial statements
5 - 7
The following pages do not form part of the financial statements
Accountants' report
8
Detailed profit and loss account
9
THE MEDISERVE CLINIC LIMITED
COMPANY INFORMATION
- 1 -
Directors
J Arian-Schad
Dr K J Ugboma
Company number
12808225
Registered office
Lynton House
7-12 Tavistock Square
London
WC1H 9BQ
Accountants
TC BSG Valentine Limited
Lynton House
7-12 Tavistock Square
London
WC1H 9BQ
THE MEDISERVE CLINIC LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 JANUARY 2026
- 2 -

The directors present their annual report and financial statements for the year ended 31 January 2026.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

J Arian-Schad
Dr K J Ugboma
Small companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

On behalf of the board
J Arian-Schad
Director
10 April 2026
THE MEDISERVE CLINIC LIMITED
STATEMENT OF INCOME AND RETAINED EARNINGS
FOR THE YEAR ENDED 31 JANUARY 2026
- 3 -
2026
2025
£
£
Turnover
231,837
-
Cost of sales
(66,814)
-
Gross profit
165,023
-
Administrative expenses
(100,979)
-
0
Other operating income
-
0
5,060
Profit before taxation
64,044
5,060
Tax on profit
(13,225)
(961)
Profit for the financial year
50,819
4,099
Retained earnings brought forward
4,099
-
0
Dividends
(25,159)
-
0
Retained earnings carried forward
29,759
4,099

The profit and loss account has been prepared on the basis that all operations are continuing operations.

THE MEDISERVE CLINIC LIMITED
BALANCE SHEET
AS AT 31 JANUARY 2026
31 January 2026
- 4 -
2026
2025
Notes
£
£
£
£
Current assets
Debtors
4
63,322
5,160
Cash at bank and in hand
12,016
-
0
75,338
5,160
Creditors: amounts falling due within one year
5
(45,479)
(961)
Net current assets
29,859
4,199
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
29,759
4,099
Total equity
29,859
4,199

For the financial year ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 10 April 2026 and are signed on its behalf by:
J Arian-Schad
Director
Company registration number 12808225 (England and Wales)
THE MEDISERVE CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026
- 5 -
1
Accounting policies
Company information

The Mediserve Clinic Limited is a private company limited by shares incorporated in England and Wales. The registered office is Lynton House, 7-12 Tavistock Square, London, WC1H 9BQ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recover ed.

1.3
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

THE MEDISERVE CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
1
Accounting policies
(Continued)
- 6 -
1.4
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

1.5
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.6
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2026
2025
Number
Number
Total
3
0
THE MEDISERVE CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 7 -
4
Debtors
2026
2025
Amounts falling due within one year:
£
£
Trade debtors
571
5,060
Other debtors
62,751
100
63,322
5,160
5
Creditors: amounts falling due within one year
2026
2025
£
£
Trade creditors
669
-
0
Corporation tax
13,225
961
Other creditors
31,585
-
0
45,479
961
THE MEDISERVE CLINIC LIMITED
MANAGEMENT INFORMATION
FOR THE YEAR ENDED 31 JANUARY 2026
THE MEDISERVE CLINIC LIMITED
REPORT TO THE DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY ACCOUNTS OF THE MEDISERVE CLINIC LIMITED
- 8 -

These financial statements have been prepared in accordance with our terms of engagement and in order to assist you to fulfil your duties under the Companies Acts that relate to preparing the financial statements of the company for the year ended 31 January 2026.

We have prepared these financial statements based on the accounting records, information and explanations provided by you. We do not express any opinion on the financial statements.

On the balance sheet, you have acknowledged your duties under the prevailing Companies Acts to ensure that the company keeps adequate accounting records and prepares financial statements that give a true and fair view.

You have determined that the company is exempt from the statutory requirement for an audit for this accounting year. Therefore, the financial statements are unaudited.

The financial statements are provided exclusively to the directors for the limited purpose mentioned above, and may not be used or relied upon for any other purpose or by any other person, and we shall not be liable for any other usage or reliance.

TC BSG Valentine Limited
10 April 2026
Lynton House
7-12 Tavistock Square
London
WC1H 9BQ
2026-01-31 2025-02-01 false true false CCH Software CCH Accounts Production 2025.300 No description of principal activity J Arian-Schad Dr K J Ugboma 12808225 2025-02-01 2026-01-31 12808225 bus:Director1 2025-02-01 2026-01-31 12808225 bus:Director2 2025-02-01 2026-01-31 12808225 bus:RegisteredOffice 2025-02-01 2026-01-31 12808225 2026-01-31 12808225 2024-02-01 2025-01-31 12808225 core:RetainedEarningsAccumulatedLosses 2025-01-31 12808225 core:RetainedEarningsAccumulatedLosses 2024-01-31 12808225 core:ShareCapital 2026-01-31 12808225 core:ShareCapital 2025-01-31 12808225 core:RetainedEarningsAccumulatedLosses 2026-01-31 12808225 core:RetainedEarningsAccumulatedLosses 2025-01-31 12808225 2025-01-31 12808225 core:RetainedEarningsAccumulatedLosses 2024-02-01 2025-01-31 12808225 core:CurrentFinancialInstruments core:WithinOneYear 2026-01-31 12808225 core:CurrentFinancialInstruments core:WithinOneYear 2025-01-31 12808225 core:CurrentFinancialInstruments 2026-01-31 12808225 core:CurrentFinancialInstruments 2025-01-31 12808225 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 12808225 bus:FRS102 2025-02-01 2026-01-31 12808225 bus:AuditExemptWithAccountantsReport 2025-02-01 2026-01-31 12808225 bus:FullAccounts 2025-02-01 2026-01-31 xbrli:pure xbrli:shares iso4217:GBP